Skip to main content

Table 1 Percentage of silent (SM) and truncating mutations (TM) affecting genes with different copy number alterations

From: Revealing selection in cancer using the predicted functional impact of cancer mutations. Application to nomination of cancer drivers

Cancer

 

Gene copy number alterations

P-val (-1)

P-val (+1)

  

-1

0

1

2

  

breast

CNA:

13

64

21

2

  
 

SM:

12

65

22

2

  
 

TM:

17

64

18

2

<10-6

1.0E-06

lung

CNA:

12

63

22

3

  
 

SM:

11

63

22

3

  
 

TM:

13

62

22

3

2.1E-05

3.9E-01

colon

CNA:

12

71

17

1

  
 

SM:

11

71

17

1

  
 

TM:

14

72

14

1

1.1E-03

4.2E-04

brain

CNA:

14

76

8

3

  
 

SM:

13

76

8

3

  
 

TM:

15

75

7

2

9.0E-06

4.9E-02

kidney

CNA:

12

76

11

0

  
 

SM:

10

76

14

1

  
 

TM:

16

71

12

0

<10-6

1.2E-01

ovarian

CNA:

23

51

24

2

  
 

SM:

21

53

24

2

  
 

TM:

30

49

19

2

<10-6

<10-6

  1. Silent mutations are distributed similar to distributions of CNA. Truncating mutations are distributed significantly differently as compared to silent mutations: over-presented in regions of heterozygous deletions; under-presented in regions of copy gains